Aussie healthcare stocks drop after Trump's latest tariff plan on pharmaceuticals

** Australian healthcare stocks .AXHJ fall as much as 2.5%, their lowest level since November 6, 2023

** The biotech giant CSL CSL.AX falls as much as 4.1% to A$189.80, its lowest level since April 23, 2019

** Telix Pharmaceuticals TLX.AX down as much as 3.9%, among the biggest drags in the S&P/ASX 200 benchmark index .AXJO, which is down 0.2%

** U.S. President Donald Trump says Washington will impose a 100% tariff on imports of branded or patented pharmaceutical products from October 1, unless a pharmaceutical company is building a manufacturing plant in the United States

** Sub-index currently down 1.4%, bringing YTD losses to 17.6%